Acquisition

September 1, 2026 To To Listing Department, The Corporate Relations Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED BSE LIMITED Exchange Plaza, Phiroz Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (E), 25th floor, Dalal Street, MUMBAI -400 051 MUMBAI -400 001 Company Code No. AUROPHARMA Company Code No. 524804 Dear Sir / Madam, Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is to inform you that Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company has incorporated a new wholly owned subsidiary by the name of ‘Avogent Lifesciences Private Limited’ in India. The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part A of Schedule III of the aforesaid regulations, is attached as ‘Annexure A’. This is for your information and records. Yours faithfully, For AUROBINDO PHARMA LIMITED B. Adi Reddy Company Secretary Enclosures: Annexure A Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India. Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044. Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038 Telangana., India Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833 Email: info@aurobindo.com Website: www.aurobindo.com Annexure ·A Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 a) Name of the target entity, details in brief such Name: Avogent Lifesciences Private Limited’ as size, turnover etc.; Turnover: Not applicable as the company was incorporated on August 31, 2026 b) Whether the acquisition would fall within Avogent Lifesciences Private Limited’ is incorporated as related party transaction(s) and whether the a wholly owned subsidiary of Apitoria Pharma Private promoter / promoter group / group companies Limited, a wholly owned subsidiary of the Company and have any interest in the entity being acquired? If therefore is a related party of the Company. Promoters yes, nature of interest and details thereof and and promoter group of the Company are not interested whether the same is done at "arms-length"; in the transaction c) Industry to which the business of the target Pharmaceuticals entity being acquired belongs; d) Objects and effects of acquisition (including The object of incorporation of this wholly owned but not limited to, disclosure of reasons for subsidiary is to undertake manufacturing and marketing acquisition of target entity, if its business is operations in India and foreign countries. outside the main line of business of the listed entity); e) Brief details of any governmental or regulatory No governmental or regulatory approvals required. approvals required for the acquisition. f) Indicative time period for completion of the Not applicable acquisition. g) Nature of consideration - whether cash 100% subscription to the share capital in cash consideration or share swap or any other form and details of the same; h) Cost of acquisition and / or the price at which Initial subscription to the share capital of Rs. the shares are acquired; New Subsidiary was 5,00,00,000 divided into 50,00,000 equity shares of incorporated. Rs.10 each. i) Percentage of shareholding / control acquired 100% and or number of shares acquired; j) Brief background about the entity acquired in This is a newly incorporated company and therefore the terms of products/line of business acquired, date history of the last 3 years’ turnover is not available. of incorporation, history of last 3 years turnover, country in which the acquired entity has Avogent Lifesciences Private Limited’ was incorporated presence and any other significant information on August 31, 2026 in India. (in brief); Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India. Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044. Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038 Telangana., India Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833 Email: info@aurobindo.com Website: www.aurobindo.com